Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2

This study has been completed.

Study NCT00050726 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: December 17, 2002 Last Updated: July 14, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2006
Primary Completion Date:	April 2006 (Final data collection date for primary outcome measure)